Achmea Investment Management B.V. Seagen Inc. Transaction History

Achmea Investment Management B.V.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$127.59 - $203.08 $2.99 Million - $4.77 Million	-23,468 Reduced 99.02%	232 $47,000
Q4 2022 Feb 09, 2023	BUY	$117.37 - $139.17 $1.41 Million - $1.67 Million	12,026 Added 103.02%	23,700 $2.85 Million
Q3 2022 Oct 27, 2022	BUY	$135.27 - $180.11 $1.55 Million - $2.06 Million	11,442 Added 4931.9%	11,674 $1.6 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $27,749 - $36,621	232 New	232 $33,000
Q4 2021 Feb 10, 2022	SELL	$142.57 - $190.86 $693,032 - $927,770	-4,861 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $692,449 - $825,495	4,861 New	4,861 $825,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.